The current valuation score of Rezolute Inc is 6.27, ranking 340 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.01, which is -88.83% below the recent high of -0.67 and -94.96% above the recent low of -11.71.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.